Skip to content

The Effect of Methylphenidate on Decision-making Ability of Attention Deficit Hyperactivity Disorder (ADHD) Adults

The Effect of Methylphenidate on Decision-making Ability of ADHD Adults

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01040702
Enrollment
58
Registered
2009-12-30
Start date
2008-01-31
Completion date
2009-12-31
Last updated
2009-12-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention Deficit Hyperactivity Disorder

Brief summary

The aim of the study is to assess the effect of Methylphenidate on cognitive performance and decision-making ability of ADHD adults, and to compare this effect to the effect on healthy control adults.

Detailed description

Two matched groups of adults - with and without ADHD diagnosis - will perform a battery of computerized tasks assessing sustained attention,working-memory,non-verbal IQ,and decision-making ability. In each group,half of the participants will perform the tasks after receiving a capsule containing methylphenidate (MPH), and the other half will perform the tasks after receiving placebo. Task performance measures will then be compared in order to assess the effect of MPH on these domains.

Interventions

DRUGmethylphenidate

a single doses of 10-20 mg in each one of two visits

DIETARY_SUPPLEMENTsweetener pill

a capsule containing a sweetener pill

Sponsors

Shalvata Mental Health Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
21 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* adults in the age of 21-50

Exclusion criteria

* pregnant or nursing women. * people who suffer from a psychiatric disorder other than ADHD which could account for their inattention symptoms better than ADHD. * people who lack judgment or are unable to communicate with the experimenters. * people who are incapable of performing the computerized tasks due to sensory or motor disabilities.

Design outcomes

Primary

MeasureTime frame
score in decision-making task 1by the end of the task

Secondary

MeasureTime frame
working memory task scoreby the end of the task

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026